宣泰医药：产品西格列汀二甲双胍缓释片（Ⅱ）续约纳入国家医保目录
Sinotherapeutics Sinotherapeutics (SH:688247) Zheng Quan Shi Bao Wang·2025-12-08 08:39

Core Viewpoint - XuanTai Pharmaceutical (688247) announced on December 8 that its product, Sitagliptin Metformin Extended-Release Tablets (II), has been included in the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List (2025) through a national negotiation renewal [1] Company Summary - The product is an oral compound hypoglycemic drug [1]